The safety profile of the regimen was also found to be comparable to Biktarvy. ・Merck now intends to present findings from the trial at a future science congress and submit applications to health ...

In the last year, over 40 million people in the world were living with human immunodeficiency virus (HIV). In 2024, over a ...

UCSF researchers have found a treatment for HIV that shows potential as a long-term solution for the chronic disease that, up ...

HIV treatment has delivered life-altering advantages. Antiretroviral therapy has led to a reduced mortality and improved life ...

In the small study, seven out of ten participants maintained low levels of HIV for several months after receiving the ...

Since the HIV epidemic began, the diagnosis of HIV has evolved from a death sentence to a chronic, but manageable condition by starting and staying on treatment. HIV treatment can help people live ...

For the University of California, San Francisco (UCSF) study, 10 people living with HIV took a mix of experimental ...

An FDA‑approved medication called spironolactone, often prescribed for heart and blood pressure conditions, may be a useful ...

The Month-12 results, drawn from study sites in Kenya, Uganda, and South Africa, offer renewed hope for improved treatment adherence, fewer HIV-related deaths, and better overall quality of life for ...

A cancer patient in Germany is the 7th person to achieve long-term HIV remission after a stem cell transplant.

An FDA‑approved medication called spironolactone, often prescribed as a diuretic, or water pill, for heart and blood pressure ...

People with HIV have an added risk of heart failure, so they and their health care providers need to be alert for early signs such as shortness of breath, fatigue, leg swelling, coughing, and chest ...